about
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experienceCabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experienceSynergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.Functional significance of CD105-positive cells in papillary renal cell carcinoma.Case 2/2016 - 76-Year-Old Male with Hypertensive Heart Disease, Renal Tumor and ShockBiomarker and competing endogenous RNA potential of tumor-specific long noncoding RNA in chromophobe renal cell carcinoma.The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway.Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma.Surgical treatment of kidney tumors - contemporary trends in clinical practice.New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapyHigh expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.Ubiquitin ligase SMURF1 functions as a prognostic marker and promotes growth and metastasis of clear cell renal cell carcinoma.Predicting Molecular Models: Where Are We Going?Less overdiagnosis of kidney cancer? an age-period-cohort analysis of incidence trends in 16 populations worldwide.Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.RIP1-dependent reactive oxygen species production executes artesunate-induced cell death in renal carcinoma Caki cells.The rationale and the role of lymph node dissection in renal cell carcinoma.Precision medicine from the renal cancer genome.Obesity and Kidney Cancer.Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis.When to perform preoperative chest computed tomography for renal cancer staging.Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies.A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1.PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinomaComplete response after treatment with first-line targeted anti-vascular endothelial growth factor therapy in metastatic renal cancer: what next?Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.Impact of marital status on renal cancer patient survival.Marital status and survival of patients with kidney cancer.Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion.Prognostic Value of Clinical and Pathological Features in Chinese Patients with Chromophobe Renal Cell Carcinoma: A 10-Year Single-Center Study.
P2860
Q28068959-3831F382-5578-4ABB-B5D5-12405A892E50Q28072166-F2494800-27E1-489A-A438-5E0A672EFA49Q33591468-06A2A9CB-3406-4CA7-A478-99A58742A8DAQ33728210-2349BAAC-ED25-40A2-8EFE-204915CD7A0BQ33733228-CDD70A02-D0F6-4D95-8B37-DD584A6F9A6DQ35859957-E0E9B3D3-3FA8-4EF3-B1EF-156B1CA2B071Q36241043-93DE96B6-FD08-40CE-BC9B-1DC046BED246Q37021355-72DF974D-87CB-4EDD-B224-6553878A6AC2Q37362007-2F9E7DA5-A379-40BF-82BF-48CF50057D66Q37426764-5646785F-C324-4CC5-836B-1185B635B39DQ37580356-82FDF3AB-EF5F-4069-AAA0-E4A58D1AA52CQ37602815-AF9C52A4-C646-4BD6-B867-500F5E76B627Q37620907-626E9BF5-0B74-4870-9090-8887CA818A56Q37702565-09EA7473-9125-44E7-8873-6444B85E1977Q37717383-81092D4C-F3C3-414B-BA55-AA5813B0E7BBQ37734791-23D2CE81-877B-451A-A829-C0B03BC6CA7FQ38255286-83652420-22CA-4BD2-A1D4-96512E351DD0Q38400821-AB42012A-9AD5-434C-A68D-9F9B3E65070AQ38698964-DD87774F-594C-42A7-B0F6-020350A95FCFQ38699390-156DC74A-5D07-4842-BFE2-7C8A5F459E44Q38807587-E9521F3A-4E13-4931-8940-5C50ED6FB570Q38882558-C4DDACB0-641E-4A6A-B3CD-790F98DFFB81Q38970282-44FFA9C2-137F-401C-A3AA-692650DC3035Q39026652-40042FB4-428A-4027-80C0-904FF0665872Q39175825-79C1275B-F18A-4FC0-BEA0-D307DBF41889Q39339598-635FF6E8-E580-42C3-82F8-5015472916B4Q40191068-6D9169C3-DAB1-4E25-ADFC-65B536502018Q41035533-5F8F1457-D311-42D9-B78A-43107626E05BQ41162248-4B16FFD7-9A36-45D2-8BC3-1A66CFAD567AQ41242139-D2E6E179-A2F8-400B-90E9-9CC3E4CB1A80Q41532653-318E5B88-2D3D-47E4-8162-2495A8B7C6A7Q41574276-D23A04FF-FA47-44D7-A6DB-3DA7750F7272Q41912541-D56951E3-E451-44D0-8F49-EB10DBB6645DQ41920336-9F8EF9FA-6564-4326-B3AF-B03622CF7A36Q42288643-47540615-9FBF-4EF0-9751-4EEB9481B70CQ42378418-CE56029E-E5F0-440C-BE79-38421BFDAEF1Q43658326-B470D3EC-7E2E-4447-AB5E-5AFF2F794B9AQ45324487-5886E5EA-CDDC-4C14-A787-EDC59427575CQ47114426-FE6FDCE9-3E1F-4814-B54E-70B35E2A2574Q47119931-B70E3EED-F5CA-4131-9185-0879652360E3
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Renal cancer.
@en
Renal cancer.
@nl
type
label
Renal cancer.
@en
Renal cancer.
@nl
prefLabel
Renal cancer.
@en
Renal cancer.
@nl
P1433
P1476
Renal cancer
@en
P2093
Francesco Montorsi
P304
P356
10.1016/S0140-6736(15)00046-X
P407
P577
2015-08-25T00:00:00Z